Our expertise in biopharma and biotech investments.
With decades of experience and a robust network within the biopharma and biotech industries, our team offers unparalleled insight into the scientific and financial landscapes. We are dedicated to identifying transformative therapies and supporting companies that are pioneering the future of healthcare.
Empowering entrepeneurs to build leading companies
Biovance Capital works closely with entrepreneurs to build leading companies with transformative treatments for patients in need.
- Stage: We invest in early-stage companies at seed and Series A rounds across Europe, with a focus in Southern countries.
- Technology: We invest in biotech companies developing therapeutics in any modality and therapeutic area. We require robust and appropriate preclinical models and patented or patentable assets before investing.
- Market: Large target market with a clear regulatory pathway for approval, with favorable reimbursement and pricing policies.
- Exit Potential: Sectors with VC/M&A or IPO activity, featuring profitable exits and multiple potential acquirers.
- Sustainability: During the due diligence process, sustainability risks are taken into account, and whenever identified, mitigation measures are proposed.